HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-06-03Clinical Trial Update: Increasing HIV Testing in Urban Emergency Departments Via Mobile Technology [NA]
An update on a clinical trial investigating mobile technology to increase HIV testing in urban emergency departments.
-
FDA approval · 2014-06-02FDA Approved: REYATAZ — Original Application (E.R. Squibb & Sons, L.L.C.)
FDA approves REYATAZ (atazanavir) under its original NDA filed by E.R. Squibb & Sons, L.L.C. for the treatment of HIV-1 infection.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir [Phase 4]
Phase 4 study update examining HCV evolution in HIV/HCV coinfected patients (genotype 1) treated with Fosamprenavir. The trial status is com…
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: CNS (Central Nervous System) Viral Dynamics and Cellular Immunity During AIDS
Completed clinical trial update from Vanderbilt University examining CNS viral dynamics and cellular immunity in individuals with HIV infect…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy [Phase 4]
Phase 4 trial evaluating lamivudine (3TC) or emtricitabine (FTC) monotherapy as a bridging strategy versus continuing HAART in HIV infection…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Non-Surgical Circumcision When Performed by Nurses [NA]
A cohort field study evaluating safety and efficacy of the PrePex non-surgical circumcision device when performed by nurses; the trial statu…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients
This is a completed observational study evaluating the tolerability of PREZISTA (darunavir) or INTELENCE (etravirine) in HIV-1–infected pati…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Juvenile Detention to Community Life [NA]
Completed clinical trial evaluating a transition program for youths leaving juvenile detention, focusing on substance use, delinquency, and …
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine [Phase 1]
Phase 1 trial assessing safety and immunogenicity of the EuroNeut41 HIV vaccine has been completed. The study was sponsored by PX'Therapeuti…
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine [Phase 1]
This Phase 1 trial update reports safety and immunogenicity data for the EN41-UGR7C HIV vaccine. The study sponsored by PX'Therapeutics has …
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects [Phase 4]
The CogNaive Study, a Phase 4 trial, has completed and assessed changes in neurocognitive function in treatment-naïve HIV-1 positive subject…
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites
IMPAACT P1073 evaluated Immune Reconstitution Inflammatory Syndrome in infants and children initiating HAART at international sites; the stu…
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy [Phase 4]
Phase 4 clinical trial evaluating the pharmacology of antimalarial therapy with or without antiretroviral therapy; the study status is TERMI…
-
CLINICAL_TRIALS withdrawal · 2014-05-19Clinical Trial Update: A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 Administered as an Oral Suspension to Healthy Adult Subjects [Phase 1]
Phase 1 pharmacokinetic and excretion study of 14C-GSK2248761 in healthy adults was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China
This is a completed clinical trial (NCT00346762) evaluating host and viral factors in HIV-infected former commercial blood donors in Fuyang,…
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV [NA]
A National Heart, Lung, and Blood Institute-sponsored trial evaluated acipimox for improving hyperlipidemia and insulin sensitivity in HIV-i…
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Safety and Acceptability of the PrePex™ Device for Male Circumcision in Zambia [Phase 4]
Phase 4 trial in Zambia assessed safety and acceptability of the PrePex male circumcision device for HIV prevention; the study completed and…
-
FDA approval · 2014-05-12FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
The FDA has approved a supplemental application for Tivicay (dolutegravir) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS research · 2014-05-09Clinical Trial Update: Non-enrolment and Non-adherence to HIV Care in a Community-based Program, Rakai, Uganda [NA]
A completed study update describing non-enrolment and non-adherence to HIV care in a community-based program in Rakai, Uganda.
-
FDA approval · 2014-05-08FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for Prezista (darunavir) by Janssen Products LP, resulting in an expanded regulatory approval.
-
FDA approval · 2014-05-08FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for PREZISTA (darunavir) from Janssen Products LP.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: DCVax Plus Poly ICLC in Healthy Volunteers [Phase 1]
Phase 1 clinical trial of DCVax Plus Poly ICLC in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations [Phase 1]
A Phase 1 exploratory study evaluated the rectal safety of three tenofovir gel formulations for HIV prevention and has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children. [Phase 1]
Phase I pharmacokinetic study of nevirapine extended-release (XR) in HIV-1 infected children. The trial has completed and results were poste…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications [Phase 1]
A Phase 1 trial evaluated potential interactions between buprenorphine and HIV and tuberculosis medications; the study has completed.